首页> 外文期刊>Proteomics >A statistical selection strategy for normalization procedures in LC-MS proteomics experiments through dataset-dependent ranking of normalization scaling factors.
【24h】

A statistical selection strategy for normalization procedures in LC-MS proteomics experiments through dataset-dependent ranking of normalization scaling factors.

机译:通过归一化缩放因子的数据集相关排名,在LC-MS蛋白质组学实验中用于归一化程序的统计选择策略。

获取原文
获取原文并翻译 | 示例
           

摘要

Quantification of LC-MS peak intensities assigned during peptide identification in a typical comparative proteomics experiment will deviate from run-to-run of the instrument due to both technical and biological variation. Thus, normalization of peak intensities across an LC-MS proteomics dataset is a fundamental step in pre-processing. However, the downstream analysis of LC-MS proteomics data can be dramatically affected by the normalization method selected. Current normalization procedures for LC-MS proteomics data are presented in the context of normalization values derived from subsets of the full collection of identified peptides. The distribution of these normalization values is unknown a priori. If they are not independent from the biological factors associated with the experiment the normalization process can introduce bias into the data, possibly affecting downstream statistical biomarker discovery. We present a novel approach to evaluate normalization strategies, which includes the peptide selection component associated with the derivation of normalization values. Our approach evaluates the effect of normalization on the between-group variance structure in order to identify the most appropriate normalization methods that improve the structure of the data without introducing bias into the normalized peak intensities.
机译:由于技术和生物学上的差异,在典型的比较蛋白质组学实验中,在肽段鉴定过程中分配的LC-MS峰强度的定量将与仪器的运行时间不同。因此,跨LC-MS蛋白质组学数据集的峰强度标准化是预处理的基本步骤。但是,选择的归一化方法会极大地影响LC-MS蛋白质组学数据的下游分析。 LC-MS蛋白质组学数据的当前归一化程序是在归一化值的背景下提出的,归一化值来自已识别肽的完整集合的子集。这些归一化值的分布是先验未知的。如果它们不独立于与实验相关的生物学因素,则归一化过程会向数据中引入偏差,可能会影响下游的统计生物标志物发现。我们提出了一种新的方法来评估归一化策略,其中包括与归一化值相关的肽选择成分。我们的方法评估归一化对组间方差结构的影响,以便确定最合适的归一化方法,这些方法可以改善数据结构,而不会在归一化的峰强度中引入偏差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号